ADH2 Gene Polymorphisms Are Determinants of Alcohol Pharmacokinetics
Authors:
- 1 December 1995
- journal article
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 19 (6) , 1494-1499
Abstract
The class I hepatic alcohol dehydrogenases (ADHs) are primarily responsible for ethanol metabolism in humans. Genetic polymorphism at the ADH2 locus results in the inheritance of isozymes of strikingly different catalytic properties. The most common ADH2 allele, ADH2*1, encodes the low Km isozyme subunit β1. The ADH2*3 allele encodes a high‐activity isozyme subunit of alcohol dehydrogenase, β3, identified in ∼25% of African‐Americans. The Vmax of β3β3‐ADH is 30 times greater than that of the β1β1‐ADH. Therefore, we hypothesized that the rate of ethanol metabolism, an important factor in the toxicity of ethanol, in persons with β3‐containing ADH, either β3β3‐ or β1β3‐ADH, would be faster than that of persons with only β1β1‐ADH. We tested this hypothesis with ethanol administered orally to healthy, young African‐Americans. Three hundred and twenty‐six African‐American men and women were genotyped using polymerase chain reaction amplification of their leukocyte DNA followed by hybridization with allele‐specific probes. One hundred twelve volunteers, selected by genotype, received an oral dose of ethanol designed to produce a blood ethanol concentration of 80 mg/dl (0.080 g/dl), when the blood alcohol concentration‐time curve was extrapolated back to time 0. Ethanol metabolic rates (β60s) were determined in the 112 subjects from the slope of the pseudolinear portion of the blood ethanol concentration‐time curves. The mean β60 of African‐Americans having β3‐containing ADH isozymes had significantly faster ethanol elimination rates than those with only β1β1‐ADH isozymes. There were no significant differences in body weight, ethanol intake in the week before testing, peak breath ethanol concentration, time to peak, or volume of distribution between the genotype groups. Within each of these groups, men had lower ethanol disappearance rates than women. These results demonstrate in vivo the kinetic differences of ADH2 isozymes that may influence individual risk for the effects of ethanol.Keywords
This publication has 21 references indexed in Scilit:
- Genetic Factors in Alcohol Metabolism and AlcoholismSeminars in Liver Disease, 1993
- Genotyping of human alcohol dehydrogenases at the ADH2 and ADH3 loci following DNA sequence amplificationGenomics, 1988
- Clinical Pharmacokinetics of EthanolClinical Pharmacokinetics, 1987
- The human β3 alcohol dehydrogenase subunit differs from β1 by a cys for Arg-369 substitution which decreases NAD(H) bindingBiochemical and Biophysical Research Communications, 1987
- Ethanol metabolismPharmacology & Therapeutics, 1987
- Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholismHepatology, 1986
- A twin study of ethanol metabolismBehavior Genetics, 1985
- Sex-related differences among 100 patients with alcoholic liver disease.BMJ, 1977
- A study of possible factors influencing the variation in liver alcohol dehydrogenase activity in individuals of the ‘usual’ ADH phenotypeAnnals of Human Genetics, 1974
- Alcohol Metabolism: Role of Microsomal Oxidation in vivoScience, 1969